col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

International Research and Cooperation Association for Bio & Socio-Sciences Advancement: BioScience Trends
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―14 The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo
2 [GO] 2021―Jul―12 Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures Tatsuo Sawakami, Kenji Karako, Peipei Song, Wataru Sugiura, Norihiro Kokudo
3 [GO] 2021―Jun―30 Rapid evolution of the COVID-19 pandemic calls for a unified public health response Na He
4 [GO] 2021―Jun―25 Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza Qian Li, Jun Wang, Haiwei Lv, Hongzhou Lu
5 [GO] 2021―Jun―15 Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19 Jie Su, Hongzhou Lu
6 [GO] 2021―Jun―15 What is always necessary throughout efforts to prevent and control COVID-19 and other infectious diseases? A physical containment strategy and public mobilization and management Mingyu Luo, Jimin Sun, Zhenyu Gong, Zhen Wang
7 [GO] 2021―Mar―25 Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease Ying Lv, Yuanyuan Ma, Yanhui Si, Xiaoyi Zhu, Lin Zhang, Haiyan Feng, et al. (+5)
8 [GO] 2021―Mar―25 Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health Lin Zhang, Ling Chai, Yihong Zhao, Lin Wang, Wenxiu Sun, Lingqing Lu, et al. (+2)
9 [GO] 2021―Mar―18 COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer Yamin Chen, Luying Cheng, Rongna Lian, Ziwei Song, Jinhui Tian
10 [GO] 2021―Mar―18 New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals Jun Chen, Hongzhou Lu
11 [GO] 2021―Feb―22 Transitional care during COVID-19 pandemic in Japan: Calls for new strategies to integrate traditional approaches with information and communication technologies Yuka Sumikawa, Noriko Yamamoto-Mitani
12 [GO] 2021―Jan―28 Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021 Kenji Karako, Peipei Song, Yu Chen, Wei Tang, Norihiro Kokudo
13 [GO] 2020―Dec―26 Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? Masashi Ohe, Ken Furuya, Houman Goudarzi
14 [GO] 2020―Dec―24 Latest updates on COVID-19 vaccines Qian Li, Hongzhou Lu
15 [GO] 2020―Dec―17 Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China Yi Su, Yun Ling, Yuyan Ma, Lili Tao, Qing Miao, Qingfeng Shi, et al. (+3)
16 [GO] 2020―Oct―24 An overview of potential therapeutic agents to treat COVID-19 Xueqin Dong, Zhenxue Tian, Chengwu Shen, Cuirong Zhao
17 [GO] 2020―Oct―24 The development of a quarantine strategy is an important path to a normalized response to COVID-19 Han Zhu, Hongzhou Lu
18 [GO] 2020―Jun―20 Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China Mingshan Xue, Peiyan Zheng, Xiqing Bian, Zhifeng Huang, Huimin Huang, Yifeng Zeng, et al. (+6)
19 [GO] 2020―Jun―11 Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19 Xianmin Meng, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, Hongzhou Lu
20 [GO] 2020―May―27 Predicting intervention effect for COVID-19 in Japan: state space modeling approach Genya Kobayashi, Shonosuke Sugasawa, Hiromasa Tamae, Takayuki Ozu
21 [GO] 2020―May―15 Does immune privilege result in recovered patients testing positive for COVID-19 again? Jufeng Xia
22 [GO] 2020―May―08 Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staff Chenjie Dong, Yuan Tian, Wenzhong Xu, Jiangjiang He, Duo Chen, Jie Zhu, Ping Lu
23 [GO] 2020―Apr―29 Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China Ying Zou, Hongying Guo, Yuyi Zhang, Zhengguo Zhang, Yu Liu, Jiefei Wang, et al. (+2)
24 [GO] 2020―Apr―26 Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic Zhiming Zhao, Mengyang Li, Rong Liu
25 [GO] 2020―Apr―21 Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up Jiao Zhang, Shoucai Wu, Lingzhong Xu
26 [GO] 2020―Apr―21 A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient Yin Kang, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, et al. (+2)
27 [GO] 2020―Apr―12 Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) Jianjun Gao, Shasha Hu
28 [GO] 2020―Apr―04 Macrolide treatment for COVID-19: Will this be the way forward? Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya, Houman Goudarzi
29 [GO] 2020―Mar―31 Mobile field hospitals, an effective way of dealing with COVID-19 in China: sharing our experience Zhi Chen, Shan He, Fan Li, Junxiang Yin, Xiaoliang Chen
30 [GO] 2020―Mar―18 Analysis of COVID-19 infection spread in Japan based on stochastic transition model Kenji Karako, Peipei Song, Yu Chen, Wei Tang
31 [GO] 2020―Feb―24 COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern Peipei Song, Takashi Karako
32 [GO] 2020―Feb―18 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Jianjun Gao, Zhenxue Tian, Xu Yang
33 [GO] 2020―Feb―16 Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China Xu Wang, Xiaoxi Zhang, Jiangjiang He
34 [GO] 2020―Feb―08 Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang
35 [GO] 2020―Jan―27 Drug treatment options for the 2019-new coronavirus (2019-nCoV) Hongzhou Lu


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.004 sec